Stepped care versus standard cognitive-behavioral therapy for obsessive-compulsive disorder: A preliminary study of efficacy and costs

Depression and Anxiety

Volumn 28, Issue 4, 2011, Pages 314-323

  Tolin, David F ^a,b   Diefenbach, Gretchen J ^a,b   Gilliam, Christina M ^a  

^a INSTITUTE OF LIVING   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Behavior therapy; Cost effectiveness; Exposure and response prevention; Health economics; Obsessive compulsive disorder; Stepped care

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COUNSELING; EXPOSURE AND RESPONSE PREVENTION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; OBSESSIVE COMPULSIVE DISORDER; PATIENT SATISFACTION; PILOT STUDY; PRIORITY JOURNAL; REHABILITATION; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

ADULT; BIBLIOTHERAPY; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COST-BENEFIT ANALYSIS; COUNSELING; FEMALE; HEALTH CARE COSTS; HUMANS; IMPLOSIVE THERAPY; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY ASSESSMENT; PSYCHOMETRICS; YOUNG ADULT;

EID: 79953745444     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20804     Document Type: Article

References (55)

1. Foa EB, Liebowitz MR, Kozak MJ, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005;162:151-161. (Pubitemid 40095685)
2. Cottraux J, Mollard E, Bouvard M, Marks I. Exposure therapy, fluvoxamine, or combination treatment in obsessive-compulsive disorder: one-year followup. Psychiatry Res 1993;49:63-75. (Pubitemid 23329247)
3. Fals-Stewart W, Marks AP, Schafer J. A comparison of behavioral group therapy and individual behavior therapy in treating obsessive-compulsive disorder. J Nerv Ment Dis 1993;181: 189-193. (Pubitemid 23090175)
4. Lindsay M, Crino R, Andrews G. Controlled trial of exposure and response prevention in obsessive-compulsive disorder. Br J Psychiatry 1997;171:135-139. (Pubitemid 27345145)
5. van Balkom AJ, de Haan E, van Oppen P, Spinhoven P, Hoogduin KA, van Dyck R. Cognitive and behavioral therapies alone versus in combination with fluvoxamine in the treatment of obsessive compulsive disorder. J Nerv Ment Dis 1998;186: 492-499. (Pubitemid 28378025)
6. March JS, Frances A, Carpenter D, Kahn DA. The expert consensus guideline series: treatment of obsessive-compulsive disorder. J Clin Psychiatry 1997;58.
7. Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007;164:5-53.
8. National Institute for Clinical Excellence. Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder (National Clinical Practice Guideline number CG31). London: British Psychological Society and Royal College of Psychiatrists; 2005.
9. Goisman RM, Rogers MP, Steketee GS, Warshaw MG, Cuneo P, Keller MB. Utilization of behavioral methods in a multicenter anxiety disorders study. J Clin Psychiatry 1993;54:213-218. (Pubitemid 23213596)
10. Marques L, LeBlanc NJ, Weingarden HM, Timpano KR, Jenike M, Wilhelm S. Barriers to treatment and service utilization in an internet sample of individuals with obsessive-compulsive symptoms. Depress Anxiety 2010;27:470-475.
11. Turner SM, Beidel DC, Spaulding SA, Brown JM. The practice of behavior therapy: national survey of costs and methods. Behav Therapist 1995;18:1-4.
12. Davison GC. Being bolder with the Boulder model: the challenge of education and training in empirically supported treatments. J Consult Clin Psychol 1998;66:163-167. (Pubitemid 28086818)
13. Crits-Christoph P, Chambless DL, Frank E, Brody C, Karp JF. Training in empirically validated treatments: What are clinical psychology students learning? Prof Psychol Res Pract 1995; 26:514-522.
14. Fritzler BK, Hecker JE, Losee MC. Self-directed treatment with minimal therapist contact: preliminary findings for obsessive-compulsive disorder. Behav Res Ther 1997;35:627-631. (Pubitemid 27254583)
15. Tolin DF, Hannan S, Maltby N, Diefenbach GJ, Worhunsky P, Brady RE. A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behav Ther 2007;38:179-191. (Pubitemid 46711183)
16. Nakagawa A, Marks IM, Park JM, et al. Self-treatment of obsessive-compulsive disorder guided by manual and computer-conducted telephone interview. J Telemed Telecare 2000;6: 22-26.
17. McLean PD, Whittal ML, Thordarson DS, et al. Cognitive versus behavior therapy in the group treatment of obsessive-compulsive disorder. J Consult Clin Psychol 2001;69:205-214. (Pubitemid 32488279)
18. Otto MW, Pollack MH, Maki KM. Empirically supported treatments for panic disorder: costs, benefits, and stepped care. J Consult Clin Psychol 2000;68:556-563.
19. Davison GC. Stepped care: doing more with less? J Consult Clin Psychol 2000;68:580-585.
20. Gilliam CM, Diefenbach GJ, Whiting SE, Tolin DF. Stepped care for obsessive-compulsive disorder: an open trial. Behav Res Ther 2010;48:1144-1149.
21. Tolin DF, Diefenbach GJ, Maltby N, Hannan SE. Stepped care for obsessive-compulsive disorder: A pilot study. Cogn Behav Pract 2005;12:403-414. (Pubitemid 43233667)
22. Abramowitz JS, Foa EB, Franklin ME. Exposure and ritual prevention for obsessive-compulsive disorder: effects of intensive versus twice-weekly sessions. J Consult Clin Psychol 2003;71:394-398. (Pubitemid 36323943)
23. Warren R, Thomas JC. Cognitive-behavior therapy of obsessive-compulsive disorder in private practice: an effectiveness study. J Anxiety Disord 2001;15:277-285. (Pubitemid 32594865)
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 2000.
25. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1011.
26. Goodman WK, Price LH, Rasmussen SA, et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 1989;46:1012-1016.
27. Guy W. 1976. Assessment Manual for Psychopharmacology. Washington, DC: U.S. Government Printing Office.
28. Brown TA, Di Nardo PA, Lehman CL, Campbell LA. Reliability of DSM-IV anxiety and mood disorders: implications for the classification of emotional disorders. J Abnorm Psychol 2001; 110:49-58. (Pubitemid 32205157)
29. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Personality Disorders, (SCID-II). Washington, DC: American Psychiatric Press, Inc.; 1997.
30. Arntz A, van Beijsterveldt B, Hoekstra R, Hofman A, Eussen M, Sallaerts S. The interrater reliability of a Dutch version of the Structured Clinical Interview for DSM-III-R Personality Disorders. Acta Psychiatr Scand 1992;85:394-400.
31. Maffei C, Fossati A, Agostoni I, et al. Interrater reliability and internal consistency of the structured clinical interview for DSM-IV axis II personality disorders (SCID-II), version 2.0. J Personal Disord 1997;11:279-284. (Pubitemid 27478022)
32. Ekselius L, Lindstrom E, von Knorring L, Bodlund O, Kullgren G. SCID II interviews and the SCID Screen questionnaire as diagnostic tools for personality disorders in DSM-III-R. Acta Psychiatr Scand 1994;90:120-123. (Pubitemid 24246324)
33. Steketee G, Frost R, Bogart K. The Yale-Brown Obsessive Compulsive Scale: interview versus self-report. Behav Res Ther 1996;34:675-684. (Pubitemid 26316913)
34. Holdnack J. Wechsler Test of Adult Reading Manual. San Antonio, TX: The Psychological Corporation; 2001.
35. Lovibond SH, Lovibond PF. Manual for the Depression Anxiety Stress Scales. Sydney: The Psychology Foundation of Australia; 1995.
36. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 1995;33:335-343.
37. Brown TA, Chorpita BF, Korotitsch W, Barlow DH. Psychometric properties of the Depression Anxiety Stress Scales (DASS) in clinical samples. Behav Res Ther 1997;35:79-89. (Pubitemid 27026171)
38. Borkovec TD, Nau SD. Credibility of analogue therapy rationales. J Behav Ther Exp Psychiatry 1972;3:257-260.
39. Tolin DF, Maltby N, Diefenbach GJ, Hannan SE, Worhunsky P. Cognitive-behavioral therapy for medication nonresponders with obsessive-compulsive disorder: a wait-list-controlled open trial. J Clin Psychiatry 2004;65:922-931.
40. Nguyen TD, Attkisson CC, Stegner BL. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Eval Program Plann 1983;6:299-313.
41. Stanley MA, Beck JG, Novy DM, et al. Cognitive behavioral treatment of late-life GAD. J Consult Clin Psychol 2003; 71:309-319.
42. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press; 2005.
43. Centers for Medicare and Medicaid Services. Revised 2007 Medicare Part B Physician and Nonphysician Practitioner Fee Schedule. Jacksonville, FL: First Coast Service Options, Inc.; 2007.
44. Bureau of Labor Statistics. Occupational Empolyment and Wages Summary, 2008. Washington, DC: United States Department of Labor; 2009.
45. Foa EB, Wilson R. 2001. Stop Obsessing!: How to Overcome Your Obsessions and Compulsions. New York: Bantam Books.
46. Miller WR, Rollnick S. 1991. Motivational Interviewing: Preparing People to Change Addictive Behaviors. New York: Guilford Press.
47. Jacobson NS, Follette WC, Revenstorf D. Toward a standard definition of clinically significant change. Behav Ther 1984; 17:308-311.
48. McGlinchey JB, Atkins DC, Jacobson NS. Clinical significance methods: which one to use and how useful are they? Behav Ther 2002;33:529-550.
49. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 1991;59:12-19.
50. Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR. Response versus remission in obsessive-compulsive disorder. J Clin Psychiatry 2006;67:269-276. (Pubitemid 43357474)
51. Foa EB, Kozak MJ. Mastery of Obsessive-Compulsive Disorder: A Cognitive-Behavioral Approach (Therapist Guide). New York: Oxford University Press; 1997.
52. Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. J Consult Clin Psychol 2000;68:594-602.
53. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988.
54. Hoenig JM, Heisey DM. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 2001; 55:19-24.
55. Mark TL, Gibson TM, McGuigan K, Chu BC. The effects of antidepressant step therapy protocols on pharmaceutical and medical utilization and expenditures. Am J Psychiatry 2010; 167:1202-1209.